Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT02944097

Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles

Study of the Oral Bioavailability of Trans-epsilon-viniferin and Trans-resveratrol From Native and Micellar Solubilized vineatrol30 Vine Extract

Sponsor: University of Hohenheim

Conditions Pharmacokinetics After Oral Intake Safety After Oral Intake

Interventions Vineatrol 30 micelles Vineatrol 30 native powder

Updated 7 times since 2017 Last updated: May 2, 2017 Started: Mar 31, 2015 Primary completion: May 31, 2015 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02944097, this EARLY_PHASE1 trial focuses on Pharmacokinetics After Oral Intake and Safety After Oral Intake and remains completed. Sponsored by University of Hohenheim, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Jun 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Jun 2017 [monthly]

Active Not Recruiting EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting Phase 0

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Hohenheim

Data source: University of Hohenheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stuttgart, Germany